The global cancer gene therapy market, valued at US$3.97 billion in 2024, is projected to reach US$19.97 billion by 2033 at a 19.8% CAGR. Explore drivers like CRISPR/Cas9 advances, CAR-T approvals (Kymriah, Yescarta), and rising investments amid expansions to solid tumors and FDA's nine therapies in 2024. https://finance.yahoo.com/news/cancer-gene-therapy-market-size-151300630.html